Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.

Veterinary pathology - 1 Nov 2012

Meyer A, Gruber A D, Klopfleisch R

Abstract excerpt

Canine cutaneous mast cell tumors (MCT) of different histological grades have distinct biological behaviors. However, little is known about underlying molecular mechanisms that lead to tumor development and increasing malignancy with higher tumor grade. Recent studies have identified the interleukin-2 receptor (IL-2R) subunits CD25 and CD2 as markers that distinguish nonneoplastic from neoplastic mast cells in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinogenesis
Share to Connective Tissue
Share to Dog Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-2 Receptor alpha Subunit

Share to Mast Cells

Share to Neoplasm Grading

Share to Proto-Oncogene Proteins c-kit

Share to Skin Neoplasms

Source

Identifiers

PMID: 22446323
DOI: 10.1177/0300985812439215

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.PMID 22446323Read ↗

Demographic Patterns and Immunophenotypic Characterization of Tumor–Immune Interactions in Canine Cutaneous Mast Cell TumorsSemantic proximity Read ↗

CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.Semantic proximity Read ↗

c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.Semantic proximity Read ↗

The Role of c-KIT in Tumorigenesis: Evaluation in Canine Cutaneous Mast Cell TumorsSemantic proximity Read ↗

Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?Semantic proximity Read ↗

Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and TreatmentSemantic proximity Read ↗

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.Semantic proximity Read ↗

Controversial role of mast cells in skin cancersSemantic proximity Read ↗

De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.Semantic proximity Read ↗

Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.Semantic proximity Read ↗

Data from the Danish veterinary cancer registry on the occurrence and distribution of neoplasms in dogs in Denmark.Semantic proximity Read ↗

Canine Mast Cell Tumors: Correlation of Apoptosis and Proliferation Markers with PrognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.